Plasma levels of norethindrone and effect upon ovarian function during treatment with silastic implants containing norethindrone
article
OA: closed
CC0
AI-generated summary
This study evaluated ovarian function in women treated with silastic implants containing norethindrone, finding that while initial high release rates suppressed ovulation, subsequent declines and variations allowed for occasional ovulatory activity and irregular bleeding patterns.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
The study was made to evaluate the effect upon the ovarian steroid pattern during treatment with subcutaneously implanted silastic rods containing norethindrone. Four rods, each containing 37 mg norethindrone (NET), were implanted subcutaneously in five women and left in place for 135--200 days. Plasma levels of NET, estradiol and progesterone were determined by radioimmunoassays. After an initial peak found in all subjects, the plasma level of NET declined. Great day-to-day variations of NET were found. Ovulations were suppressed during treatment in three subjects. One subject had regular ovulations throughout treatment and in one subject a single ovulation was recorded. Peaks of estradiol without subsequent ovulation were found in two subjects. The bleeding pattern was irregular; three subjects had varying degrees of spotting and bleeding, two subjects were amenorrheic. The average daily release rate was 300/micrograms, calculated from the amount of steroids lost from the removed rods. This study indicates that the release of steroid from four NET rods is high enough only initially to completely inhibit ovulation.
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
References (34)
- doi:10.1016/s0022-4804(64)80040-8 via crossref
- doi:10.1016/0002-9378(69)90140-9 via crossref
- doi:10.1016/0002-9378(69)90141-0 via crossref
- doi:10.1016/s0010-7824(75)80045-x via crossref
- doi:10.1016/0010-7824(75)90059-1 via crossref
- doi:10.1016/0010-7824(74)90036-5 via crossref
- doi:10.1016/s0010-7824(76)80011-x via crossref
- doi:10.1016/0010-7824(75)90105-5 via crossref
- doi:10.1016/0010-7824(74)90018-3 via crossref
- doi:10.1016/0010-7824(75)90004-9 via crossref
- doi:10.1016/0010-7824(72)90024-8 via crossref
- doi:10.1530/acta.0.0710716 via crossref
- doi:10.1016/0010-7824(77)90009-9 via crossref
- doi:10.1016/0010-7824(76)90120-7 via crossref
- doi:10.1530/acta.0.0630216 via crossref
- doi:10.1530/acta.0.0640038 via crossref
- doi:10.1016/s0010-7824(76)80039-x via crossref
- W1497590080 via openalex
- W1725334162 via openalex
- W1744573208 via openalex
- W1967748130 via openalex
- W1983337026 via openalex
- W1993162450 via openalex
- W2017977343 via openalex
- W2038677670 via openalex
- W2051503974 via openalex
- W2052951538 via openalex
- W2066857322 via openalex
- W2120127545 via openalex
- W2133385176 via openalex
- W2140005015 via openalex
- W2148421954 via openalex
- W2151130195 via openalex
- W2169614806 via openalex
Source provenance
- crossref
- last seen: 2026-05-16T01:00:20.974634+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- unpaywall
- last seen: 2026-10-02T06:31:42.897446+00:00
License: CC0
· commercial use OK